• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Computational drug repurposing: approaches, evaluation of in silico resources and case studies
 
  • Details
  • Full
Options
2025
Review
Title

Computational drug repurposing: approaches, evaluation of in silico resources and case studies

Abstract
Repurposing of existing drugs for new indications has attracted substantial attention owing to its potential to accelerate drug development and reduce costs. Hundreds of computational resources such as databases and predictive platforms have been developed that can be applied for drug repurposing, making it challenging to select the right resource for a specific drug repurposing project. With the aim of helping to address this challenge, here we overview computational approaches to drug repurposing based on a comprehensive survey of available in silico resources using a purpose-built drug repurposing ontology that classifies the resources into hierarchical categories and provides application-specific information. We also present an expert evaluation of selected resources and three drug repurposing case studies implemented within the Horizon Europe REMEDi4ALL project to demonstrate the practical use of the resources. This comprehensive Review with expert evaluations and case studies provides guidelines and recommendations on the best use of various in silico resources for drug repurposing and establishes a basis for a sustainable and extendable drug repurposing web catalogue.
Author(s)
Tanoli, Ziaurrehman Ur Rehman
Helsingin Yliopisto
Fernández-Torras, Adrià
Parc Científic de Barcelona
Özcan, Umut Onur
Helsingin Yliopisto
Kushnir, Aleksandr
Helsingin Yliopisto
Nader, Kristen Michelle
Helsingin Yliopisto
Gadiya, Yojana  
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Fiorenza, Laura
Politecnico di Milano
Ianevski, Aleksandr
Helsingin Yliopisto
Vähä-Koskela, Markus
Helsingin Yliopisto
Miihkinen, Mitro
Helsingin Yliopisto
Seemab, Umair
Itä-Suomen yliopisto
Leinonen, Henri O.
Itä-Suomen yliopisto
Seashore-Ludlow, Brinton A.
Karolinska Institutet
Tampere, Marianna
Karolinska Institutet
Kalman, Adelinn
Karolinska Institutet
Ballante, Flavio
Karolinska Institutet
Benfenati, Emilio B.
Istituto di Ricerche Farmacologiche Mario Negri
Saunders, Gary Ian
EATRIS ERIC
Potdar, Swapnil
Helsingin Yliopisto
Gómez García, Ismael
Parc Científic de Barcelona
García-Serna, Ricard
Parc Científic de Barcelona
Talarico, Carmine
Dompé Farmaceutici S.p.A
Beccari, Andrea Rosario
Dompé Farmaceutici S.p.A
Schaal, Wesley
Uppsala Universitet
Polo, Andrea
Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli
Costantini, Susan
Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli
Cabri, Enrico
Istituto di Ricerche Farmacologiche Mario Negri
Jacobs, Marc  
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
Saarela, Jani S.
Helsingin Yliopisto
Budillon, Alfredo D.O.
Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli
Spjuth, Ola
Uppsala Universitet
Östling, Päivi
Karolinska Institutet
Xhaard, Henri
Helsingin Yliopisto
Quintana, Jordi
Parc Científic de Barcelona
Mestres, Jordi
Parc Científic de Barcelona
Gribbon, Philip  
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Ussi, Anton E.
EATRIS ERIC
Lo, Donald C.
EATRIS ERIC
Kort, Martin de
EATRIS ERIC
Wennerberg, Krister
Biotech Research & Innovation Centre
Fratelli, Maddalena M.
Istituto di Ricerche Farmacologiche Mario Negri
Carreras-Puigvert, Jordi
Uppsala Universitet
Aittokallio, Tero A.
Helsingin Yliopisto
Journal
Nature reviews. Drug discovery  
DOI
10.1038/s41573-025-01164-x
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024